Validation of the 8th Edition of the UICC/AJCC Staging System for Nasopharyngeal Carcinoma From Endemic Areas in the Intensity-Modulated Radiotherapy Era
- PMID: 28687579
- DOI: 10.6004/jnccn.2017.0121
Validation of the 8th Edition of the UICC/AJCC Staging System for Nasopharyngeal Carcinoma From Endemic Areas in the Intensity-Modulated Radiotherapy Era
Abstract
Background: In this study, we evaluated the 8th edition of the Union for International Cancer Control (UICC)/AJCC staging system for nasopharyngeal carcinoma (NPC) in an endemic area, with the aim of validating its applicability and providing further information for future refinements. Methods: A total of 1,790 patients with newly diagnosed, non-distant metastatic, histologically proven NPC treated with intensity-modulated radiotherapy (IMRT) were retrospectively reviewed. The performance of various staging systems was compared using the Akaike information criterion (AIC) and Harrell's concordance index (c-index). Results: For N (node) category, the survival curves of different groups according to the 8th edition were well-separated, and the prognostic model predicted outcomes fairly well. The 8th edition had higher AIC and c-index values for all end points than the 7th edition. However, probably due to the improved locoregional control provided by IMRT, the survival curves for T2 and T3 almost overlapped, without significant differences in locoregional failure-free survival (P=.606) and disease-free survival (P=.735). Due to the difficultly of differentiating T2 and T3, the AIC and c-index values were similar for the T categories of the 7th and 8th editions. Similarly, the overall survival and disease-free survival curves for stage II and III disease were not clearly separated for either the 8th or 7th editions. Conclusions: The 8th edition of the UICC/AJCC staging system for NPC enables more accurate prediction of treatment outcomes. However, several limitations need to be addressed in future editions, and it would be reasonable to further optimize the T category classification.
Copyright © 2017 by the National Comprehensive Cancer Network.
Similar articles
-
Comparison of the seventh and eighth editions of the UICC/AJCC staging system for nasopharyngeal carcinoma: analysis of 1317 patients treated with intensity-modulated radiotherapy at two centers.BMC Cancer. 2018 May 29;18(1):606. doi: 10.1186/s12885-018-4419-1. BMC Cancer. 2018. PMID: 29843648 Free PMC article.
-
Validation of the 8th edition of AJCC/UICC staging system for nasopharyngeal carcinoma: Results from a non-endemic cohort with 10-year follow-up.Oral Oncol. 2019 Nov;98:141-146. doi: 10.1016/j.oraloncology.2019.09.029. Epub 2019 Oct 4. Oral Oncol. 2019. PMID: 31586896
-
Comparing the 7th and 8th editions of UICC/AJCC staging system for nasopharyngeal carcinoma in the IMRT era.BMC Cancer. 2021 Mar 30;21(1):327. doi: 10.1186/s12885-021-08036-8. BMC Cancer. 2021. PMID: 33785010 Free PMC article.
-
The updated points of TNM classification of urological cancers in the 8th edition of AJCC and UICC.Jpn J Clin Oncol. 2019 May 1;49(5):421-425. doi: 10.1093/jjco/hyz017. Jpn J Clin Oncol. 2019. PMID: 30844068 Review.
-
Treatment strategy for de novo metastatic nasopharyngeal carcinoma: a literature review.Chin Clin Oncol. 2023 Aug;12(4):43. doi: 10.21037/cco-23-32. Chin Clin Oncol. 2023. PMID: 37699604 Review.
Cited by
-
Dual-energy CT for the detection of skull base invasion in nasopharyngeal carcinoma: comparison of simulated single-energy CT and MRI.Insights Imaging. 2023 May 24;14(1):95. doi: 10.1186/s13244-023-01444-3. Insights Imaging. 2023. PMID: 37222846 Free PMC article.
-
An Individualized Prognostic Model in Patients with Locoregionally Advanced Nasopharyngeal Carcinoma Based on Serum Metabolomic Profiling.Life (Basel). 2023 May 11;13(5):1167. doi: 10.3390/life13051167. Life (Basel). 2023. PMID: 37240811 Free PMC article.
-
Advances in Nasopharyngeal Carcinoma Staging: from the 7th to the 9th Edition of the TNM System and Future Outlook.Curr Oncol Rep. 2025 Mar;27(3):322-332. doi: 10.1007/s11912-025-01651-9. Epub 2025 Feb 25. Curr Oncol Rep. 2025. PMID: 39998781 Review.
-
Nomogram-Based Prediction of Survival in Stage IV Nasopharyngeal Carcinoma: A Retrospective Single-Center Study.Diagnostics (Basel). 2025 May 23;15(11):1309. doi: 10.3390/diagnostics15111309. Diagnostics (Basel). 2025. PMID: 40506880 Free PMC article.
-
Concurrent chemoradiotherapy combined with nimotuzumab in stage III-IVa nasopharyngeal carcinoma: a retrospective analysis.J Cancer Res Clin Oncol. 2023 Jun;149(6):2327-2344. doi: 10.1007/s00432-022-04355-w. Epub 2022 Oct 27. J Cancer Res Clin Oncol. 2023. PMID: 36289067 Free PMC article. Clinical Trial.
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources